Serum Glutamate Is a Predictor for the Diagnosis of Multiple Sclerosis
One neurotransmitter, glutamate, has been implicated in the autoimmune demyelination seen in multiple sclerosis (MS). Glutamate is present in many tissues in the body, so consideration should be given to whether the serum level of glutamate is likely well correlated with the activity of the disease....
Saved in:
| Main Authors: | Gheyath Al Gawwam, Inas K. Sharquie |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | The Scientific World Journal |
| Online Access: | http://dx.doi.org/10.1155/2017/9320802 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact Of Clinical Pharmacist-Led Interventions on Short Term Quality Of Life Among Multiple Sclerosis Patients Taking Disease-Modifying Therapy
by: Zahraa Abbas Munaf, et al.
Published: (2025-03-01) -
Detection of opioid growth factor in Multiple Sclerosis Patients
by: Khamael Abdulla Taha, et al.
Published: (2020-12-01) -
Neurophysiological Changes in Post Stroke Spasticity Patients
by: Safa Fawzi, et al.
Published: (2023-01-01) -
Analysis of probable predictors of aggressive multiple sclerosis
by: N. N. Spirin, et al.
Published: (2020-01-01) -
Clinical predictors of response to immunomodulators for multiple sclerosis
by: Guilherme Sciascia do Olival, et al.
Published: (2012-01-01)